StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.26−0.03 (-0.20%)

Close on Nov 18, 2026Market cap $82.16MP/E 3.3Yield –

Rallybio pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Rallybio's pe ratio was 2.0× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.0×–

More Rallybio figures

See a number that looks wrong?